Antiviral therapeutics in dentistry.
Rapid progress is being made in the development of antiviral therapy. This review restricts its focus to antivirals that may be used by dental practitioners, principally those agents active in herpesvirus infections.
Epstein
J B
JB
Vancouver General Hospital, University of British Columbia.
D000212:Acyclovir / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003729:Dental Care; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D017245:Foscarnet; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host; D007372:Interferons / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D014765:Viral Vaccines
D000998:Antiviral Agents; D004338:Drug Combinations; D009705:Nucleosides; D014765:Viral Vaccines; D017245:Foscarnet; D007372:Interferons; D010746:Phosphonoacetic Acid; D000212:Acyclovir